Journal of the Pediatric Infectious Diseases SocietyImmunologyPeer-reviewed journal article
Antibody-mediated cellular responses are dysregulated in Multisystem Inflammatory Syndrome in Children (MIS-C)
Jenna K. DickiD, Jules A. SangalaiD, Venkatramana Divana KrishnaiD, Aaron KhaimrajiD, Lydia HameliD, Spencer M EricksoniD, Dustin HicksiD, Yvette Soigner, Laura E CovilliD, Alexander K. JohnsoniD, Michael J. EhrhardtiD, Keenan ErnsteiD, Petter BrodiniD, Richard A. KoupiD, Alka KhaitaniD, Carly BaehriD, Beth Kristine ThieleniD, Christine M. HenzleriD, Caleb P SkipperiD, Jeffrey S. MilleriD, Yenan T. BrycesoniD, Jianming WuiD, Chandy C. JohniD, Angela Panoskaltsis‐MortariiD, Alberto OriolesiD, , Geoffrey T. HartiD
Abstract
Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe complication of SARS-CoV-2 infection characterized by multi-organ involvement and inflammation. Testing of cellular function ex vivo to understand the aberrant immune response in MIS-C is limited. Despite strong antibody production in MIS-C, SARS-CoV-2 nucleic acid testing can remain positive for 4-6 weeks after infection. Therefore, we hypothesized that dysfunctional cell-mediated antibody responses downstream of antibody production may be responsible for delayed clearance of viral products in MIS-C. In MIS-C, monocytes were hyperfunctional for phagocytosis and cytokine production, while natural killer (NK) cells were hypofunctional for both killing and cytokine production. The decreased NK cell cytotoxicity correlated with an NK exhaustion marker signature and systemic IL-6 levels. Potentially providing a therapeutic option, cellular engagers of CD16 and SARS-CoV-2 proteins were found to rescue NK cell function in vitro. Together, our results reveal dysregulation in antibody-mediated cellular responses unique to MIS-C that likely contribute to the immune pathology of this disease. SummaryMIS-C is a severe complication of SARS-CoV-2 infection characterized by multi-organ involvement and inflammation. Limited studies tested cellular function ex vivo to understand the aberrant immune response in MIS-C. We found dysregulation in antibody-mediated cellular responses unique to MIS-C that likely contribute to the immune pathology of this disease O_FIG O_LINKSMALLFIG WIDTH=138 HEIGHT=200 SRC="FIGDIR/small/589585v1_ufig1.gif" ALT="Figure 1"> View larger version (30K): org.highwire.dtl.DTLVardef@16d9e0dorg.highwire.dtl.DTLVardef@1a37693org.highwire.dtl.DTLVardef@bdb0cforg.highwire.dtl.DTLVardef@1a32604_HPS_FORMAT_FIGEXP M_FIG O_FLOATNOGraphical abstractC_FLOATNO C_FIG
- organism: human
- assay: flow cytometry
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- approach: wet-lab / biochemical assay
- Citations
- 3
- FWCI
- 1.41
- Field percentile
- top 23%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Age-Associated Weaker Immunity to Coronaviruses is Characteristic of Children that Develop Multisystem Inflammatory Syndrome following SARS-CoV-2 Infection
D. Camerini, A. Arrieta, … D. Nugent·bioRxiv·Aug 28, 2023
- Neutrophil Profiles of Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children
B. P. Boribong, T. J. LaSalle, … L. M. Yonker·bioRxiv·Dec 18, 2021
- A monocyte/dendritic cell molecular signature of SARS-CoV2-related multisystem inflammatory syndrome in children (MIS-C) with severe myocarditis
C. de Cevins, M. Luka, … Gras Leguen·MedPeer-reviewed·Sep 1, 2021
- Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome
R. A. Porritt, L. Paschold, … M. Arditi·bioRxiv·Nov 9, 2020
- Global Absence and Targeting of Protective Immune States in Severe COVID-19.
A. J. Combes, T. Courau, … M. F. Krummel·bioRxiv·Oct 28, 2020
- Absence of severe COVID-19 in patients with clonal mast cells activation disorders: effective anti-SARS-CoV-2 immune response.
J. Rossignol, A. Ouedrani, … Mania·bioRxiv·Sep 1, 2021